european medicines agency news - Search News

European Committee Takes a Second Look at Alzheimer's Drug

Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved.

The Associated Press - Busines… · 3d

European committee takes a second look at Alzheimer’s drug and now says it should be approved

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.

Medical Xpress · 3d

European watchdog partially approves new Alzheimer's drug

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.

EU regulators endorse meds from BMS, J&J, Eisai and more—plus a clutch of biosims

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

Pharmalittle: We’re reading about an Alzheimer’s drug about-face, Bavarian Nordic’s views on Trump, and more

Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...

emjreviews.com1d

EU Rejects Majority of US Fast-Tracked Cancer Drugs

A new study reveals that more than half of cancer drugs approved by the FDA under accelerated pathways are not authorized in ...

2d

Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early Alzheimer's Disease

Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced a positive opinion has been received from the Committee for Medicinal ...

Aurobindo Pharma's Triumph: EU GMP Certification for Biosimilars

Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received a GMP certificate from the European Medicines Agency for its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results